Cited by 3,162Cancer Genomics and DiagnosticsCancer Cells and MetastasisEvolution and Genetic Dynamics

The DOI matches its Crossref record; 104 of the 107 references it cites were found in a registry or an index, and 3 are not checked yet.

Clonal evolution in cancer

Open access

Greaves, Mel, Maley, Carlo C.·2012·Nature

DOI 10.1038/nature10762PMC PMC3367003

Open this paper in CoChat — free account

Abstract

Cancers evolve by a reiterative process of clonal expansion, genetic diversification and clonal selection within the adaptive landscapes of tissue ecosystems. The dynamics are complex, with highly variable patterns of genetic diversity and resulting clonal architecture. Therapeutic intervention may destroy cancer clones and erode their habitats, but it can also inadvertently provide a potent selective pressure for the expansion of resistant variants. The inherently Darwinian character of cancer is the primary reason for this therapeutic failure, but it may also hold the key to more effective control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature10762

Cites

104 of 107 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Önder, T. T., Jiang, G., Tao, K. X., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,429
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253

Show all 104 references

Sorted by citations

Items 901–1,000 of 1,004

Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
Wu, Y., Biswas, D., & Swanton, C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.013 · Cited by 43
Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity
Relecom, A., Merhi, M., Inchakalody, V. P., Shahab Uddin, M. S., Rinchai, D., Bedognetti, D., & Dermime, S. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01872-3 · Cited by 41
Gene Duplication and Gene Fusion Are Important Drivers of Tumourigenesis during Cancer Evolution
Glenfield, C., & Innan, H. (2021) · Genes · doi:10.3390/genes12091376 · Cited by 41
Telomerase as a therapeutic target in glioblastoma
Aquilanti, E., Kageler, L., Wen, P. Y., & Meyerson, M. M. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab203 · Cited by 41
Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
Banz‐Jansen, C., Helweg, L. P., & Kaltschmidt, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063412 · Cited by 41
Tumor-associated neutrophils: orchestrating cancer pathobiology and therapeutic resistance
Bui, T. M., Yalom, L. K., & Sumagin, R. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1954162 · Cited by 42
Traits of a mussel transmissible cancer are reminiscent of a parasitic life style
Burioli, E. A. V., Hammel, M., Bierne, N., Frédéric Thomas, A., Houssin, M., Destoumieux‐Garzón, D., & Charrière, G. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-03598-w · Cited by 39
DNA Damage/Repair Management in Cancers
Alhmoud, J. F., Woolley, J. F., Moustafa, A. A., & Mallei, M. I. (2021) · doi:10.1201/9781003180449-12 · Cited by 40
Tumour Genetic Heterogeneity in Relation to Oral Squamous Cell Carcinoma and Anti-Cancer Treatment
Feller, G., Khammissa, R. A. G., Ballyram, R., Beetge, M.-M., Lemmer, J., & Feller, L. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032392 · Cited by 39
Targeting tumor metastases: Drug delivery mechanisms and technologies
Ganapathy, V., Moghe, P. V., & Roth, C. M. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.042 · Cited by 39
βArrestin-1 and Mcl-1 Modulate Self-Renewal Growth of Cancer Stem-Like Side-Population Cells in Non-Small Cell Lung Cancer
Singh, S., Bora-Singhal, N., Kroeger, J. L., Laklai, H., & Chellappan, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055982 · Cited by 39
Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia
Bochtler, T., Fröhling, S., & Krämer, A. (2015) · Leukemia · doi:10.1038/leu.2015.32 · Cited by 39
Cancer progression modeling using static sample data
Sun, Y., Yao, J. B., Nowak, N. J., & Goodison, S. (2014) · Genome biology · doi:10.1186/s13059-014-0440-0 · Cited by 38
High‐grade sarcoma diagnosis and prognosis: Biomarker discovery by mass spectrometry imaging
Lou, S., Balluff, B., de Graaff, M. A., Cleven, A. H. G., Bruijn, I. H. B., Bovée, J. V. M. G., & McDonnell, L. A. (2016) · PROTEOMICS · doi:10.1002/pmic.201500514 · Cited by 39
Quantitative histology analysis of the ovarian tumour microenvironment
Lan, C., Heindl, A., Huang, X., Xi, S., Banerjee, S. N., Liu, J., & Yuan, Y. (2015) · Scientific Reports · doi:10.1038/srep16317 · Cited by 39
New and Old Genes Associated with Topotecan Resistance Development in Ovarian Cancer Cell Lines
Klejewski, A., Świerczewska, M., Zaorska, K., Brązert, M., Nowicki, M. O., Zabel, M., & Januchowski, R. (2017) · Anticancer Research · doi:10.21873/anticanres.11493 · Cited by 39
The role of spatial variations of abiotic factors in mediating intratumour phenotypic heterogeneity
Lorenzi, T., Venkataraman, C., Lorz, A., & Chaplain, M. A. J. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.05.002 · Cited by 38
Modeling the Subclonal Evolution of Cancer Cell Populations
Chowell, D., Napier, J., Gupta, R. V., Anderson, K. S., Maley, C. C., & Sayres, M. A. W. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1229 · Cited by 40
Self-citation
Computational approaches for inferring tumor evolution from single-cell genomic data
Zafar, H., Navin, N. E., Nakhleh, L. K., & Chen, K. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.11.008 · Cited by 35
Non-canonical Estrogen Signaling in Endocrine Resistance
Ranganathan, P., Nadig, N., & Nambiar, S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00708 · Cited by 39
Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer
Mao, C., Zeng, X., Zhang, C., Yang, Y., Xiao, X., Luan, S., Zhang, Y., & Yuan, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.612451 · Cited by 38
Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
Baumeister, P., Zhou, J., Canis, M., & Gires, O. (2021) · Cancers · doi:10.3390/cancers13215355 · Cited by 43
Genome Instability in Multiple Myeloma: Facts and Factors
Aksenova, A. Y., Zhuk, A. S., Lada, A. G., Zotova, I. V., Stepchenkova, E. I., Kostroma, I. I., Gritsaev, S. V., & Pavlov, Y. I. (2021) · Cancers · doi:10.3390/cancers13235949 · Cited by 43
Hallmarks of cancer and hallmarks of aging
Blagosklonny, M. V. (2022) · Aging · doi:10.18632/aging.204082 · Cited by 43
FLT3 inhibitors for acute myeloid leukemia: successes, defeats, and emerging paradigms
Acharya, B., Saha, D., Armstrong, D., Lakkaniga, N. R., & Frett, B. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00067a · Cited by 37
Temporal recording of mammalian development and precancer
Islam, M., Yang, Y., Simmons, A. J., Shah, V. M., Pavan, M. K., Xu, Y., Tasneem, N., Chen, Z., Trinh, L. T., Molina, P., et al. (2024) · Nature · doi:10.1038/s41586-024-07954-4 · Cited by 41
Tumor heterogeneity, clonal evolution, and therapy resistance: an opportunity for multitargeting therapy.
Calderwood, S. K. (2013) · PubMed · Cited by 38
Dominant mechanisms of primary resistance differ from dominant mechanisms of secondary resistance to targeted therapies
Asić, K. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.08.004 · Cited by 38
BCR-ABL1 is a secondary event after JAK2V617F in patients with polycythemia vera who develop chronic myeloid leukemia
Wang, X., Tripodi, J., Kremyanskaya, M., Blouin, A. G., Roda, P. I., Hoffman, R., & Najfeld, V. (2013) · Blood · doi:10.1182/blood-2012-11-467787 · Cited by 38
Renal cell carcinoma: translational aspects of metabolism and therapeutic consequences
Yang, O. C. Y., Maxwell, P. H., & Pollard, P. J. (2013) · Kidney International · doi:10.1038/ki.2013.245 · Cited by 38
An expanding universe of the non-coding genome in cancer biology
Xue, B., & He, L. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu099 · Cited by 37
The evolutionary biography of chronic lymphocytic leukemia
Puente, X. S., & López-Otı́n, C. (2013) · Nature Genetics · doi:10.1038/ng.2556 · Cited by 38
Genetics of breast cancer bone metastasis: a sequential multistep pattern
Fazilaty, H., & Mehdipour, P. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9642-9 · Cited by 36
Chemical biology approaches to target validation in cancer
Blagg, J., & Workman, P. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.07.007 · Cited by 38
Quantitative implementation of the endogenous molecular–cellular network hypothesis in hepatocellular carcinoma
Wang, G., Zhu, X., Gu, J., & Ao, P. (2014) · Interface Focus · doi:10.1098/rsfs.2013.0064 · Cited by 34
How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma?
Soultati, A. S., Stares, M., Swanton, C., Larkin, J., & Turajlic, S. (2015) · Current Opinion in Urology · doi:10.1097/mou.0000000000000204 · Cited by 37
Clonal origin and spread of metastatic prostate cancer
Etten, J. L. V., & Dehm, S. M. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0049 · Cited by 40
Rab35 GTPase and cancer: Linking membrane trafficking to tumorigenesis
Shaughnessy, R., & Échard, A. (2018) · Traffic · doi:10.1111/tra.12546 · Cited by 37
Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis
Tang, Y. J., Huang, J., Tsushima, H., Ban, G. I., Zhang, H., Oristian, K. M., Puviindran, V., Williams, N. T., Ding, X., Ou, J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.029 · Cited by 38
Dissecting the multi-omics atlas of the exosomes released by human lung adenocarcinoma stem-like cells
Luo, H., Zheng, Y., Tang, J., Shao, L., Mao, Y., Yang, W. C., Yang, X., Li, Y., Tian, R., & Li, F. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00217-5 · Cited by 38
Cell-Intrinsic Mechanisms of Drug Tolerance to Systemic Therapies in Cancer
Léonce, C., Saintigny, P., & Ortiz‐Cuaran, S. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-21-0038 · Cited by 41
Modern reproductive patterns associated with estrogen receptor positive but not negative breast cancer susceptibility
Aktipis, A., Ellis, B. J., Nishimura, K. K., & Hiatt, R. A. (2014) · Evolution Medicine and Public Health · doi:10.1093/emph/eou028 · Cited by 38
Differences in the cellular composition of small versus large uterine fibroids
Holdsworth‐Carson, S. J., Zhao, D., Cann, L. M., Bittinger, S. E., Nowell, C. J., & Rogers, P. A. W. (2016) · Reproduction · doi:10.1530/rep-16-0216 · Cited by 38
Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT
Zhang, L., Yang, J., Huang, J., Yu, Y., Ding, J., Karges, J., & Xiao, H. (2024) · Chem · doi:10.1016/j.chempr.2023.12.019 · Cited by 38
Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma
Bianchi, G., & Ghobrial, I. M. (2014) · Current Cancer Therapy Reviews · doi:10.2174/157339471002141124121404 · Cited by 38
Array-Based Comparative Genomic Hybridization Analysis Reveals Chromosomal Copy Number Aberrations Associated with Clinical Outcome in Canine Diffuse Large B-Cell Lymphoma
Aricò, A., Ferraresso, S., Bresolin, S., Marconato, L., Comazzi, S., Kronnie, G. T., & Aresu, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111817 · Cited by 37
Monitoring the dynamics of clonal tumour evolution in vivo using secreted luciferases
Charles, J. P., Fuchs, J., Hefter, M., Vischedyk, J. B., Kleint, M., Vogiatzi, F., Schäfer, J., Nist, A., Timofeev, O. N., Wanzel, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4981 · Cited by 36
Spatial and temporal cancer evolution: causes and consequences of tumour diversity
Hiley, C. T., & Swanton, C. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-6-s33 · Cited by 39
Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway
El‐Ashmawy, N. E., Khedr, N. F., El‐Bahrawy, H. A., & Mansour, H. E. A. (2017) · Tumor Biology · doi:10.1177/1010428317692235 · Cited by 38
Comprehensive genetic alteration profiling in primary and recurrent glioblastoma
Neilsen, B. K., Sleightholm, R. L., McComb, R. D., Ramkissoon, S. H., Ross, J. S., Corona, R. J., Miller, V. A., Cooke, M. B., & Aizenberg, M. R. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03070-2 · Cited by 39
Differential Variation Analysis Enables Detection of Tumor Heterogeneity Using Single-Cell RNA-Sequencing Data
Davis-Marcisak, E. F., Sherman, T. D., Orugunta, P., Stein-O’Brien, G., Puram, S. V., Torres, E. T. R., Hopkins, A. C., Jaffee, E. M., Favorov, A. V., Afsari, B., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3882 · Cited by 38
Cancer and pH Dynamics: Transcriptional Regulation, Proteostasis, and the Need for New Molecular Tools
Czowski, B. J., Romero-Moreno, R., Trull, K. J., & White, K. A. (2020) · Cancers · doi:10.3390/cancers12102760 · Cited by 34
Mitochondrial DNA Mutation Analysis in Breast Cancer: Shifting From Germline Heteroplasmy Toward Homoplasmy in Tumors
Pérez-Amado, C. J., Tovar, H., Gómez-Romero, L., Beltrán‐Anaya, F. O., Bautista‐Piña, V., Domínguez-Reyes, C. A., Villegas‐Carlos, F., Tenorio‐Torres, A., Alfaro-Ruíz, L. A., Hidalgo‐Miranda, A., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572954 · Cited by 37
Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer
Bueschbell, B., Caniceiro, A. B., Suzano, P. M. S., Machuqueiro, M., Rosário‐Ferreira, N., & Moreira, I. S. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100811 · Cited by 38
Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas
Gaydosik, A. M., Stonesifer, C. J., Khaleel, A. E., Geskin, L. J., & Fuschiotti, P. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4437 · Cited by 38
Predicting the evolution of Escherichia coli by a data-driven approach
Wang, X., Zorraquino, V., Kim, M., Τσουκαλάς, Α., & Tagkopoulos, I. (2018) · Nature Communications · doi:10.1038/s41467-018-05807-z · Cited by 37
Evolution of Premalignant DiseasePreprint
Curtius, K., Wright, N. A., & Graham, T. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026542 · Cited by 38
Life History Trade-Offs in Tumors
Boddy, A. M., Huang, W., & Aktipis, A. (2018) · Current Pathobiology Reports · doi:10.1007/s40139-018-0188-4 · Cited by 37
A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis
Guo, J., Ma, X., Liu, D., Wang, F., Xia, J., Zhang, B., Zhao, P., Zhong, F., Chen, L., Long, Q., et al. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101116 · Cited by 37
Cooperative nutrient scavenging is an evolutionary advantage in cancer
Guzelsoy, G., Elorza, S. D., Ros, M., Schachtner, L. T., Hayashi, M., Hobson-Gutierrez, S., Rundstrom, P., Brunner, J. S., Pillai, R., Walkowicz, W. E., et al. (2025) · Nature · doi:10.1038/s41586-025-08588-w · Cited by 37
Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm
de Oliveira, E. A., Milite, S., Fernández-Mateos, J., Cresswell, G. D., Romero, E. Y., Vlachogiannis, G., Chen, B., James, C. T., Patruno, L., Ascolani, G., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-0999 · Cited by 46
Transmissible cancers in an evolutionary context
Újvári, B., Papenfuss, A. T., & Belov, K. (2016) · BioEssays · doi:10.1002/bies.201670904 · Cited by 36
Lung Cancer Stem Cell: Fancy Conceptual Model of Tumor Biology or Cornerstone of a Forthcoming Therapeutic Breakthrough?
Sourisseau, T., Hassan, K. A., Wistuba, I. I., Penault-Llorca, F. M., Adam, J., Deutsch, É., & Soria, J. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000028 · Cited by 36
Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine
Alberter, B., Klein, C. A., & Polzer, B. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1121099 · Cited by 36
Metronomic chemotherapy: A potent macerator of cancer by inducing angiogenesis suppression and antitumor immune activation
Biziota, E., Mavroeidis, L., Hatzimichael, E. C., & Pappas, P. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.018 · Cited by 36
The Volume of Three-Dimensional Cultures of Cancer Cells In Vitro Influences Transcriptional Profile Differences and Similarities with Monolayer Cultures and Xenografted Tumors
Boghaert, E. R., Lu, X. L., Hessler, P., McGonigal, T. P., Oleksijew, A., Mitten, M. J., Foster-Duke, K. D., Hickson, J. A., Santo, V. E., Brito, C., et al. (2017) · Neoplasia · doi:10.1016/j.neo.2017.06.004 · Cited by 34
Hypoxia-inducible factor-2 alpha up-regulates CD70 under hypoxia and enhances anchorage-independent growth and aggressiveness in cancer cells
Kitajima, S., Lee, K. L., Fujioka, M., Sun, W., You, J., Chia, G. S., Wanibuchi, H., Tomita, S., Araki, M., Kato, H., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24919 · Cited by 37
From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?
Bewersdorf, J. P., Ardasheva, A., Podoltsev, N. A., Singh, A., Biancon, G., Halene, S., & Zeidan, A. M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100587 · Cited by 37
Discrete and continuum phenotype-structured models for the evolution of cancer cell populations under chemotherapy
Stace, R. E. A., Stiehl, T., Chaplain, M. A. J., Marciniak-Czochra, A. K., & Lorenzi, T. (2020) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/2019027 · Cited by 35
Genetics and Genomics of Breast Cancer: update and translational perspectives
Biancolella, M., Testa, B., Salehi, L. B., D’Apice, M. R., & Novelli, G. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.03.013 · Cited by 34
Cancer stem cells and their niche in the progression of squamous cell carcinoma
Oshimori, N. (2020) · Cancer Science · doi:10.1111/cas.14639 · Cited by 38
The Tumor Microenvironment of Pancreatic Cancer
Karamitopoulou, E. (2020) · Cancers · doi:10.3390/cancers12103076 · Cited by 37
Reuniting philosophy and science to advance cancer research
Pradeu, T., Daignan‐Fornier, B., Ewald, A. J., Germain, P., Okasha, S., Plutynski, A., Benzekry, S., Bertolaso, M., Bissell, M. J., Brown, J. S., et al. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12971 · Cited by 37
Self-citation
Adipose-derived stem cells induced EMT-like changes in H358 lung cancer cells.
Park, Y. M., Yoo, S. H., & Kim, S.-H. (2013) · PubMed · Cited by 36
Technical Challenges in the Clinical Application of Radiomics
Shaikh, F., Kolowitz, B. J., Awan, O. A. R., Aerts, H. J. W. L., von Reden, A., Halabi, S. S., Mohiuddin, S. A., Malik, S., Shrestha, R. B., & Deible, C. R. (2017) · JCO Clinical Cancer Informatics · doi:10.1200/cci.17.00004 · Cited by 36
Self‐Triggered Apoptosis Enzyme Prodrug Therapy (STAEPT): Enhancing Targeted Therapies via Recurrent Bystander Killing Effect by Exploiting Caspase‐Cleavable Linker
Chung, S. W., Choi, J. U., Cho, Y. S., Kim, H. R., Won, T. H., Dimitrion, P. M., Jeon, O., Kim, S. W., Kim, I., Kim, S. Y., et al. (2018) · Advanced Science · doi:10.1002/advs.201800368 · Cited by 36
Quantification of subclonal selection in cancer from bulk sequencing dataPreprint
Williams, M. J., Werner, B., Curtis, C. N., Barnes, C. P., Sottoriva, A., & Graham, T. A. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/096305 · Cited by 35
Richter syndrome: Novel insights into the biology of transformation
Parry, E. M., ten Hacken, E., & Wu, C. J. (2023) · Blood · doi:10.1182/blood.2022016502 · Cited by 36
Mitophagy’s impacts on cancer and neurodegenerative diseases: implications for future therapies
Huang, J. B., Pham, V. T., Fu, S., Huang, G., Liu, Y., & Zheng, L. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01727-w · Cited by 42
Genetic Insights in Barrett’s Esophagus and Esophageal Adenocarcinoma
Reid, B. J., Paulson, T. G., & Li, X. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.010 · Cited by 35
Cancer stem cells in glioma: challenges and opportunities.
Wang, J., Ma, Y., & Cooper, M. K. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.08.01 · Cited by 35
Can oncology recapitulate paleontology? Lessons from species extinctions
Walther, V., Hiley, C. T., Shibata, D. K., Swanton, C., Turner, P. E., & Maley, C. C. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.12 · Cited by 37
Self-citation
The evolving contribution of hematopoietic progenitor cells to lymphomagenesis
Weigert, O., & Weinstock, D. M. (2012) · Blood · doi:10.1182/blood-2012-05-414995 · Cited by 40
Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell Vaccination
Oth, T., Vanderlocht, J., van Elssen, C. H. M. J., Bos, G. M. J., & Germeraad, W. T. V. (2016) · Mediators of Inflammation · doi:10.1155/2016/5740373 · Cited by 36
A systematic approach to cancer: evolution beyond selection
Miller, W. B., & Torday, J. S. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0131-4 · Cited by 35
Taming Tumor Glycolysis and Potential Implications for Immunotherapy
Ganapathy‐Kanniappan, S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00036 · Cited by 35
Nothing in cancer makes sense except…
Greaves, M. F. (2018) · BMC Biology · doi:10.1186/s12915-018-0493-8 · Cited by 36
Self-citation
Delivering Combination Chemotherapies and Targeting Oncogenic Pathways via Polymeric Drug Delivery Systems
Nair, P. R. (2019) · Polymers · doi:10.3390/polym11040630 · Cited by 37
Clonal Evolution and Changes in Two AML Patients Detected with A Novel Single-Cell DNA Sequencing Platform
Xu, L., Durruthy-Durruthy, R., Eastburn, D. J., Pellegrino, M., Shah, O., Meyer, E. H., & Zehnder, J. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-47297-z · Cited by 36
Effect of intra‐ and inter‐tumoral heterogeneity on molecular characteristics of primary IDH‐wild type glioblastoma revealed by single‐cell analysis
Xiong, Z., Yang, Q., & Li, X. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13396 · Cited by 36
The potential of long noncoding RNAs for precision medicine in human cancer
Wu, M., Zhang, X., Han, X., Pandey, V., Lobie, P. E., & Zhu, T. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.040 · Cited by 36
An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability
Hayford, C. E., Tyson, D. R., Robbins, C. T., Frick, P. L., Quaranta, V., & Harris, L. A. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3000797 · Cited by 38
Bioinspired micro/nanomotors towards a self-propelled noninvasive diagnosis and treatment of cancer
Rastmanesh, A., Yaraki, M. T., Wu, J., Wang, Z., Ghoderao, P., Gao, Y., & Tan, Y. N. (2021) · Molecular Systems Design & Engineering · doi:10.1039/d1me00065a · Cited by 35
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics
Awada, H. K., Thapa, B., Awada, H., Dong, J., Gurnari, C., Hari, P., & Dhakal, B. (2021) · Cells · doi:10.3390/cells10081961 · Cited by 35
Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma
Aoki, T., Nishida, N., & Kudo, M. (2022) · Cancers · doi:10.3390/cancers14020444 · Cited by 35
Small Molecule-Induced Mitochondrial Disruption Directs Prostate Cancer Inhibition via Unfolded Protein Response Signaling
Rico-Bautista, E., Zhu, W., Kitada, S., Ganapathy, S., Lau, E. K., Krajewski, S., Ramirez, J., Bush, J., Yuan, Z.-M., & Wolf, D. A. (2013) · Oncotarget · doi:10.18632/oncotarget.1130 · Cited by 35
Gene expression variability in clonal populations: Causes and consequences
Roberfroid, S., Vanderleyden, J., & Steenackers, H. P. L. (2016) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1122571 · Cited by 38
Influences of Allee effects in the spreading of malignant tumours
Sewalt, L., Harley, K., van Heijster, P., & Balasuriya, S. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2015.12.024 · Cited by 36
Computational frameworks transform antagonism to synergy in optimizing combination therapies
Chen, J., Lin, A., Jiang, A., Qi, C., Liu, Z., Cheng, Q., Yuan, S., & Luo, P. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01435-2 · Cited by 38
Inferring alterations in cell‐to‐cell communication in HER2+ breast cancer using secretome profiling of three cell models
Klinke, D. J., Kulkarni, Y. M., Wu, Y., & Byrne-Hoffman, C. N. N. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25238 · Cited by 35

Authors: Greaves, M., & Maley, C. C.
Affiliations: University of California, San Francisco (US)
ORCID: Maley, Carlo C.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2012-01
Volume: 481
Issue: 7381
Pages: 306-313
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10762
PMC: PMC3367003
OpenAlex: W2023560061
Cited by: 3,162
References: 104
Citations by year: 2026: 180 · 2025: 160 · 2024: 181 · 2023: 225 · 2022: 204 · 2021: 253 · 2020: 229 · 2019: 211 · 2018: 247 · 2017: 296 · 2016: 247 · 2015: 238 · 2014: 221 · 2013: 164 · 2012: 101
FWCI: 17.27
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Cancer Institute (R01CA149566, P01CA091955, U54CA143803, P01CA91955, R01CA140657)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords: clonal evolution, cancer, clonal expansion, genetic diversification, clonal selection, fitness landscape, tumor microenvironment, clonal architecture, drug resistance
MeSH terms: Animals, Clone Cells, Humans, Mutation, Neoplasms, Neoplastic Stem Cells, Genomics, Tumor Microenvironment, Clonal Evolution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clonal evolution in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks